Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus - PubMed (original) (raw)
Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus
Y Sokawa et al. Infect Immun. 1980 Jun.
Abstract
The activity of 2',5'-oligoadenylate synthetase, which is induced by interferon action, was detected in mouse trigeminal ganglia infected with herpes simplex virus (HSV) type 1. When HSV was inoculated on the left cheek of mice, the virus began to appear in the ipsilateral trigeminal ganglia on day 2, reached its maximum accumulation on day 4, declined thereafter, and was no longer detected in the tissue homogenate after 11 days. After this short acute productive phase, the virus entered into the latent phase of infection. 2',5'-Oligoadenylate synthetase appeard in the trigeminal ganglia shortly after the beginning of virus multiplication; the synthetase activity began to rise on day 3, reached a maxium level on day 4, and then declined. Interferon activity (type I) also appeared in the infected ganglia, but diminished more rapidly than the synthetase. The antibody against HSV in the sera began to appear at the time when the virus and synthetase were declining. From these results it may be hypothesized, although not concluded, that in the acute productive phase of HSV infection in mouse trigeminal ganglia, virus multiplication is suppressed by interferon action, including 2',5'-oligoadenylate synthetase induction.
Similar articles
- Human leukocyte interferon induces 2', 5'-oligo (A) polymerase and protein kinase.
Baglioni C, Maroney PA. Baglioni C, et al. Virology. 1980 Mar;101(2):540-4. doi: 10.1016/0042-6822(80)90470-5. Virology. 1980. PMID: 6244703 No abstract available. - Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells.
Hovanessian AG, Meurs E, Aujean O, Vaquero C, Stefanos S, Falcoff E. Hovanessian AG, et al. Virology. 1980 Jul 15;104(1):195-204. doi: 10.1016/0042-6822(80)90377-3. Virology. 1980. PMID: 6156539 No abstract available.
Cited by
- The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.
Schmidt DS, Eis-Hübinger AM, Schneweis KE. Schmidt DS, et al. Arch Virol. 1993;133(1-2):179-87. doi: 10.1007/BF01309753. Arch Virol. 1993. PMID: 8240008 - Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.
Karino Y, Sugawara T, Saga A, Yoshida J, Matsushima T, Miyazaki T, Toyota J, Okuuchi Y. Karino Y, et al. Gastroenterol Jpn. 1989 Apr;24(2):164-9. doi: 10.1007/BF02774192. Gastroenterol Jpn. 1989. PMID: 2744332 - (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
Schattner A, Merlin G, Bregman V, Hahn T, Levin S, Revel M, Wallach D. Schattner A, et al. Clin Exp Immunol. 1984 Aug;57(2):265-70. Clin Exp Immunol. 1984. PMID: 6467673 Free PMC article. - Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.
Sugino H, Mitani I, Koike M, Kodama T, Sokawa J, Sawai H, Ishibashi K, Itoh M, Watanabe S, Sokawa Y. Sugino H, et al. J Clin Microbiol. 1986 Sep;24(3):478-81. doi: 10.1128/jcm.24.3.478-481.1986. J Clin Microbiol. 1986. PMID: 3760142 Free PMC article.
References
- Science. 1971 Aug 27;173(3999):843-5 - PubMed
- Infect Immun. 1973 Feb;7(2):272-88 - PubMed
- Cancer Res. 1973 Jun;33(6):1399-401 - PubMed
- Science. 1974 Jun 14;184(4142):1185-7 - PubMed
- Infect Immun. 1975 Jul;12(1):166-72 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical